Wedbush analyst Sarah James raised his price target on Neutral-rated Aetna (NYSE: AET) to $103.00 (from $96.00) following Q4 results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE